Page last updated: 2024-12-07

mk 0641

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

MK 0641: combination of above cpds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56841553
MeSH IDM0123040

Synonyms (8)

Synonym
erythromycin ethylsuccinate and sulfisoxazole acetyl
mk 0641
sulfisoxazole acetyl / erythromycin ethylsuccinate
e.s.p
erythromycin ethylsuccinate / sulfisoxazole acetyl
sulfimycin
376597-07-8
mk-0641

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In this study, mean daily dosage was 40-50 mg/kg for cefaclor and 50 mg/kg ES + 150 mg/kg sulfamide for Pediazole."( [An open randomized trial, Pediazole versus cefaclor in the treatment of acute otitis media in children].
Bedbeder, P; Boucherat, M; Bouhanna, CA; Cohen, R; de La Rocque, F; Geslin, P; Peynegre, R; Reinert, P, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (41.67)18.7374
1990's6 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (58.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other4 (33.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]